Topic resource collection
Approved comparison material connected to this topic.
4 resourcesRead both sides
KPV (tripeptide) I B stabilization. Prevents NF- B nuclear translocation Direct transcription inhibition Receptor-independent (passive diffusion) Minimal. Compartmentalized effect Broad (any cell expressing NF- B pathway) Cortico…
NSAIDs (ibuprofen, naproxen) Inhibit COX-1/COX-2 enzymes, reducing prostaglandin synthesis Hours (symptom relief only) Gastric ulcers, cardiovascular risk, renal dysfunction KPV blocks upstream transcription rather than downstrea…
Topical (aqueous solution) <50 μm (stratum corneum only) 1–5 mg per application, twice daily Low. Reconstitute and apply Minimal effect expected. Poor penetration Not recommended without penetration enhancer Topical (liposomal fo…
The following table compares VIP formulation variables that determine experimental reproducibility and research outcomes. Formulation type, storage conditions, and delivery route directly impact VPAC receptor engagement and infla…